325 related articles for article (PubMed ID: 25163664)
1. How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.
Gaglio B; Phillips SM; Heurtin-Roberts S; Sanchez MA; Glasgow RE
Implement Sci; 2014 Aug; 9():96. PubMed ID: 25163664
[TBL] [Abstract][Full Text] [Related]
2. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
[TBL] [Abstract][Full Text] [Related]
3. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
Elder WG; Munk N
J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
[TBL] [Abstract][Full Text] [Related]
4. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Pragmatic Nature of Mobile Health Interventions Promoting Physical Activity: Systematic Review and Meta-analysis.
Stecher C; Pfisterer B; Harden SM; Epstein D; Hirschmann JM; Wunsch K; Buman MP
JMIR Mhealth Uhealth; 2023 May; 11():e43162. PubMed ID: 37140972
[TBL] [Abstract][Full Text] [Related]
6. Applying the pragmatic-explanatory continuum indicator summary to the implementation of a physical activity coaching trial in chronic obstructive pulmonary disease.
Nguyen HQ; Moy ML; Fan VS; Gould MK; Xiang A; Bailey A; Desai S; Coleman KJ
Nurs Outlook; 2018 Sep; 66(5):455-463. PubMed ID: 30144938
[TBL] [Abstract][Full Text] [Related]
7. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
[TBL] [Abstract][Full Text] [Related]
8. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.
Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE
Trials; 2016 Jan; 17():32. PubMed ID: 26772801
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the design and reporting of pragmatic trials in osteoarthritis research.
Ali SA; Kloseck M; Lee K; Walsh KE; MacDermid JC; Fitzsimmons D
Rheumatology (Oxford); 2018 Jan; 57(1):59-63. PubMed ID: 28371879
[TBL] [Abstract][Full Text] [Related]
10. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Dal-Ré R; Janiaud P; Ioannidis JPA
BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
[TBL] [Abstract][Full Text] [Related]
11. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise.
Palese A; Bevilacqua MG; Dante A;
J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115
[TBL] [Abstract][Full Text] [Related]
12. Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.
Gastaldon C; Mosler F; Toner S; Tedeschi F; Bird VJ; Barbui C; Priebe S
PLoS One; 2019; 14(9):e0222891. PubMed ID: 31550279
[TBL] [Abstract][Full Text] [Related]
13. Applying the PRECIS criteria to describe three effectiveness trials of weight loss in obese patients with comorbid conditions.
Glasgow RE; Gaglio B; Bennett G; Jerome GJ; Yeh HC; Sarwer DB; Appel L; Colditz G; Wadden TA; Wells B
Health Serv Res; 2012 Jun; 47(3 Pt 1):1051-67. PubMed ID: 22092292
[TBL] [Abstract][Full Text] [Related]
14. Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings.
Glasgow RE; Estabrooks PE
Prev Chronic Dis; 2018 Jan; 15():E02. PubMed ID: 29300695
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.
Forbes G; Loudon K; Treweek S; Taylor SJC; Eldridge S
J Clin Epidemiol; 2017 Oct; 90():119-126. PubMed ID: 28629699
[TBL] [Abstract][Full Text] [Related]
17. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.
Dal-Ré R
Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910
[TBL] [Abstract][Full Text] [Related]
18. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA
JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763
[TBL] [Abstract][Full Text] [Related]
19. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review.
Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L
BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028
[TBL] [Abstract][Full Text] [Related]
20. Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.
Forbes G; Loudon K; Clinch M; Taylor SJC; Treweek S; Eldridge S
Trials; 2019 Dec; 20(1):711. PubMed ID: 31829266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
